When Toyota Motor Corp.’s (NYSE: TM)�U.S. sales collapsed four years ago, and did not make any recovery for three, most industry analysts blamed recalls and the effects of the 2011 Japan earthquake on production. In addition, and probably as important as the other two, there was the rise of the South Korean car industry, which offered Americans what Japanese models once did — low prices with good quality. The fortunes of manufacturers have turned sharply. Japan’s leader, Toyota, has gained back much of its share. Hyundai’s share has fallen.
New forecasts for August cars sales from KBB show that Toyota’s market share will stay at 14.7%, the same as August a year ago. That would put it virtually tied with Ford Motor Co. (NYSE: F), which currently holds the second spot behind General Motors Co. (NYSE: GM). Toyota will sell 214,000 cars and trucks this month, up 13.5% . Hyundai and its sister brand Kia will show a sales improvement of only�7.1%. That figure seems impressive at first, but it is not compared to an expected improvement of 13.6%, to an August total of 1.46 million, for the entire industry.
Top Solar Stocks To Own Right Now: Ivanhoe Energy Inc (IVAN)
Ivanhoe Energy Inc. (Ivanhoe), incorporated on February 21, 1995, is an independent international heavy oil development and production company. Ivanhoe�� core operations are in Canada, Ecuador, China and Mongolia, with business development opportunities worldwide. Ivanhoe�� wholly owned subsidiary, Sunwing Energy Ltd. (Sunwing) is focused on a natural gas exploration project (the Zitong Block) in Sichuan Province of China. The Sichuan Basin is located in central China approximately 930 miles southwest of Beijing. Its oil and gas operations are located in three geographic areas: Asia, Canada and Ecuador. In December 2012, the Company had closed the Share Purchase and Sale Agreement with MIE Holdings Corporation for all of the interest of its indirect, wholly owned subsidiary, Pan-China Resources Ltd.
Asia
In China, Sunwing operates the 659,840-acre (1,031-square-miles) Zitong gas exploration block in the Sichuan Province, and it holds a 90% Contractor Interest in a Petroleum Contract with PetroChina Company Limited. Mitsubishi Gas Chemical Company of Japan holds the remaining 10% Contractor Interest. Sunwing produces approximately 1,800 (gross) barrels of light oil per day in Dagang, in China's Hebei province, in a production sharing agreement with Petrochina in which Sunwing is the operator and maintains a royalty interest in the revenue stream from its first project carried out in the Daqing Oil Field. In November 2002, the Company entered into a 30 year production sharing contract (PSC) with China National Petroleum Corporation (CNPC) for the Zitong block, which covers an area of approximately 248,000 gross acres after contractual relinquishments in the Sichuan basin.
During the year ended December 31, 2006, the Company farmed out 10% of its working interest in the Zitong block to Mitsubishi Gas Chemical Company Inc. of Japan. In Phase I of the contract, Ivanhoe reprocessed 1,649 miles of two dimensional (2D) seismic data and acquired 705 miles of new 2D s! eismic data. In Phase II of the contract, the Yixin-2 and Zitong-1 gas wells were drilled during the year ended December 31, 2010, and completed during the year ended December 31, 2011. Ivanhoe�� oil production originates in the Kongnan oilfield in Dagang, Hebei Province, China (the Dagang field). In 2011, production in averaged 967 barrels per day net. The Company�� Nyalga Block XVI is in the Khenti and Tov provinces in Mongolia. The block covers an area of approximately 3.1 million gross acres, after a 25% relinquishment in 2010.
Canada
Ivanhoe holds a 100% working interest in the Tamarack Project, subject only to a 20% back-in right held by Talisman Energy. Tamarack is a 6,880 acre lease located approximately 10 miles northeast of Fort McMurray, Alberta, Canada. The Tamarack integrated oil sands project (Tamarack Project) consists of a two-phased 40,000 bbl/d steam-assisted gravity drainage thermal recovery (SAGD) and HTL facility.
Ecuador
The Company's activities in Latin America are carried out under its wholly owned subsidiary, Ivanhoe Energy Latin America Inc. Ivanhoe Energy Ecuador Inc., a Canadian company is a wholly owned subsidiary of Ivanhoe Energy Latin America Inc. and is responsible for the Company's activities in Ecuador. In October 2008, Ivanhoe Energy Ecuador Inc. had signed a 30 year contract with the Ecuador state oil companies Petroecuador and Petroproduccion. The contract gives Ivanhoe the right to explore and develop the Pungarayacu heavy oil field in Block 20, an area of 426 square miles, approximately 125 miles southeast of Quito, Ecuador�� capital city. Block 20 is an area of approximately 426-square-miles (1,103.34-square-kilometers) located 125 miles (201.17 kilometers) southeast of Quito. Block 20 contains the 250-square-mile (647.5-square-kilometer) Pungarayacu oil field. In 2010, Ivanhoe drilled its two appraisal wells in the Pungarayacu field. The second, IP-5b, well was drilled, cored and logged to a total depth ! of 1,080 ! feet. The well was perforated in the Hollin oil sands and steam was injected into the reservoir resulting in production of heated heavy oil. In 2011, the heavy crude oil extracted from the IP-5B well was upgraded to local pipeline specifications using Ivanhoe�� HTL upgrading process. In 2011, the Company completed a 190-kilometer 2-D seismic survey over the southern portion of Block 20.
Advisors' Opinion:- [By Stephan Dube]
Athabasca's most notable producers:
Suncor Energy (SU) (Part 1), see article here.Suncor Energy (Part 2), see article here.Athabasca Oil (ATHOF.PK), see article here.Canadian Natural Resources, see article here.Imperial Oil, see article here.Cenovus Energy (CVE), see article here.MEG Energy (MEGEF.PK), see article here.Devon Energy, see article here.Royal Dutch Shell, see article here.Ivanhoe Energy (IVAN), see article here.Nexen (CNOOC) (CEO), see article here.An analysis of the current operations of the company will be examined with the objective to provide the most complete information available to potential investors before deciding to seize the opportunity that the 54,132 square miles of the Carbonate Triangle has to offer. Let's start by introducing Athabasca, a famous and most prolific region in the Canadian oil sands as well as one of the largest reserve in the world.
Best Japanese Companies For 2014: Senesco Technologies Inc (SNTI)
Senesco Technologies, Inc., incorporated on September 30. 1999, is engaged in utilize its eukaryotic translation initiation Factor 5A, or Factor 5A, and deoxyhypusine synthase (DHS), and related technologies for human therapeutic applications to develop approaches to treat cancer and inflammatory diseases. In agricultural applications, the Company has licensed applications of the Factor 5A, DHS and Lipase platforms to develop the productivity of fruits, flowers, vegetables, agronomic and biofuel feedstock crops through the control of cell death and growth in plants.
Human Therapeutic Applications
The Company has developed a therapeutic candidate, SNS01-T, an improved formulation of SNS01, for the potential treatment of multiple myeloma and non-Hodgkin B-cell lymplomas. SNS01-T utilizes the Company's Factor 5A technology and consists of two components, which include a DNA plasmid (pDNA), expressing human eIF5A containing a lysine to arginine substitution at amino acid position 50, (eIF5AK50R), and a small inhibitory RNA (siRNA). These two components are combined in a fixed ratio with a polymer, polyethyleneimine (PEI), which enables self-assembly of the DNA and RNA into nanoparticles with demonstrated enhanced delivery to tissues and protection from degradation in the blood stream. The Company has also demonstrated that the combination of lenalidomide and SNS 01-T performs better than either treatment alone in mouses xenograft models of human mantle cell lymphoma. The Company's human therapeutic research program, which consists of pre-clinical in-vitro and in-vivo experiments designed to assess the role and mode of action of Factor 5A in human diseases and a phase 1a/2b clinical trial.
The Company competes with Celgene, Inc., Takeda/Millennium, ONYX Pharmaceuticals, Inc., Amgen Inc., Janssen Biotech, Inc., Novartis AG, and Pharmacyclics, Inc.
Agricultural Applications
The Company's agricultural research focuses on the discovery and develo! pment of certain gene technologies, which are designed to confer positive traits on fruits, flowers, vegetables, forestry species and agronomic crops. The Company's research and development initiatives for agriculture include develop and implement the DHS and Factor 5A gene technology in banana, canola, cotton, turfgrass, rice, alfalfa, corn, soybean and trees; and test the resultant crops for new beneficial traits such as increased yield, increased tolerance to environmental stress, disease resistance and more efficient use of fertilizer.
The Company competes with Mendel Biotechnology, Renessen LLC, Exelixis Plant Sciences, Inc., and Syngenta International AG.
Advisors' Opinion:- [By Peter Graham]
At the end of last week, small cap stocks Senesco Technologies, Inc (OTCBB: SNTI), VolitionRX Ltd (OTCMKTS: VNRX) and Micromem Technologies Inc (OTCBB: MMTIF) were all trending upwards ��ending up 13.65%, 8.73% and 7.61%, respectively, on Friday. However, it�� a new trading week with the last two trading days for the year. So what direction will these three small caps head in for the end of this year and into next year? Here is a quick look to help you decide on a trading or investment strategy:
- [By CRWE]
Today, SNTI has shed (-2.44%) down -0.0010 at $.0400 with�723,673 shares in play thus far (ref. google finance Delayed: 2:58PM EDT October 7, 2013).
Senesco Technologies, Inc. previously reported it has entered into a securities purchase agreement with certain investors to raise $1.725 million in gross proceeds through the sale of 69,000,000 shares of its common stock. The common stock was priced at $0.025 per share.
The offering is expected to close on or about October 2, 2013, subject to customary closing conditions. The net proceeds of the financing will be used primarily for working capital, research and development and general corporate purposes.
Best Japanese Companies For 2014: J&J Snack Foods Corp (JJSF)
J & J Snack Foods Corp. (J & J), incorporated in 1971, manufactures nutritional snack foods and distributes frozen beverages, which it markets nationally to the food service and retail supermarket industries. The Company�� principal snack food products are soft pretzels marketed under the brand name SUPERPRETZEL and frozen juice treats and desserts marketed under the LUIGI��, WHOLE FRUIT, ICEE and MINUTE MAID brand names. In June 2012, the Company acquired the assets of Kim & Scott�� Gourmet Pretzels, Inc., a manufacturer and seller of a brand soft pretzel. In October 2013, J & J Snack Foods Corp. acquired the assets of New York Pretzel.
J & J is a manufacturer of soft pretzels in the United States, Mexico and Canada. Other snack food products include churros (an Hispanic pastry), funnel cake, dough enrobed handheld products and bakery products. The Company�� principal frozen beverage products are the ICEE brand frozen carbonated beverage and the SLUSH PUPPIE brand frozen uncarbonated beverage. The Company�� Food Service and Frozen Beverages sales are made to food service customers, including snack bar and food stand locations in chain, department, discount, warehouse club and convenience stores; malls and shopping centers; fast food outlets; stadiums and sports arenas; leisure and theme parks; movie theatres; independent retailers, and schools, colleges and other institutions. The Company�� retail supermarket customers are supermarket chains. The Company operates in three business segments: Food Service, Retail Supermarkets and Frozen Beverages.
The products sold by the food service segment are soft pretzels, frozen juice treats and desserts, churros, dough enrobed handheld products and baked goods. Its customers in the food service segment include snack bars and food stands in chain, department and discount stores; malls and shopping centers; casual dining restaurants; fast food outlets; stadiums and sports arenas; leisure and theme parks; convenience stores; m! ovie theatres; warehouse club stores; schools, colleges, and other institutions. The products sold to the retail supermarket channel are soft pretzel products, including SUPERPRETZEL, frozen juice treats and desserts, including LUIGI�� Real Italian Ice, MINUTE MAID Juice Bars and Soft Frozen Lemonade, WHOLE FRUIT frozen fruit bars and sorbet, ICEE Squeeze-Up Tubes and dough enrobed handheld products, including PATIO burritos. The Company sells frozen beverages to the food service industry primarily under the names ICEE, SLUSH PUPPIE, PARROT ICE and ARCTIC BLAST in the United States, Mexico and Canada. It also provides repair and maintenance service to customers for customers��owned equipment.
Soft Pretzels
The Company�� soft pretzels are sold under many brand names, which are SUPERPRETZEL, PRETZEL FILLERS, PRETZELFILS, GOURMET TWISTS, MR. TWISTER, SOFT PRETZEL BITES, SOFTSTIX, SOFT PRETZEL BUNS, TEXAS TWIST, CINNAPRETZEL and SERIOUSLY TWISTED!; and under private labels. Soft pretzels are sold in the Food Service and Retail Supermarket segments. During fiscal year ended September 29, 2012 (fiscal 2012), soft pretzel sales amounted to 18% of the Company�� revenue.
Soft pretzels, ranging in size from one to ten ounces in weight, are shaped and formed by the Company�� twister machines. These soft pretzel tying machines are for twisting dough into the traditional pretzel shape. In addition, it makes soft pretzels, which are extruded or shaped by hand. The Company�� marketing program in the Food Service segment includes supplying ovens, mobile merchandisers, display cases, warmers and similar merchandising equipment to the retailer to prepare and promote the sale of soft pretzels.
Frozen Juice Treats and Desserts
The Company�� frozen juice treats and desserts are marketed primarily under the LUIGI��, WHOLE FRUIT, ICEE and MINUTE MAID brand names. Frozen juice treats and desserts are sold in the Food Service and Retail Supermarke! ts segmen! ts. During fiscal 2012, frozen juice treats and dessert sales were 13% of the Company�� revenue.
The Company�� school food service MINUTE MAID and WHOLE FRUIT frozen juice bars and cups are manufactured from an apple or pineapple juice concentrate to which water, sweeteners, coloring (in some cases) and flavorings are added. The juice bars are produced in various flavors and are packaged in a sealed push-up paper container referred to as the Milliken M-pak. The balance of the Company�� frozen juice treats and desserts products are manufactured from water, sweeteners and fruit juice concentrates in various flavors and packaging, including cups, tubes, sticks, M-paks, pints and tubs.
Churros
The Company�� churros are sold under the TIO PEPE�� and CALIFORNIA CHURROS brand names. Churros are sold to the Food Service and Retail Supermarkets segments. During fiscal 2012, Churro sales were 6% of the Company�� sales. Churros are Hispanic pastries in stick form, which the Company produces in several sizes. The churros are deep fried, frozen and packaged. At food service point-of-sale they are reheated and topped with a cinnamon sugar mixture. The Company also sells fruit and creme-filled churros. The Company supplies churro merchandising equipment.
Handheld Products
The Company's dough enrobed handheld products are marketed under the PATIO, HAND FULLS, HOLLY RIDGE BAKERY, VILLA TALIANO, TOP PICKS brand names and under private labels. Handheld products are sold to the Food Service and Retail Supermarket segments. During fiscal 2012, handheld product sales amounted to 6% of the Company's sales.
Bakery Products
The Company�� bakery products are marketed under the MRS. GOODCOOKIE, READI-BAKE, COUNTRY HOME, MARY B��, DADDY RAY�� and JANA�� brand names, and under private labels. Bakery products include biscuits, fig and fruit bars, cookies, breads, rolls, crumb, muffins and donuts. Bakery products are sold ! to the Fo! od Service segment. During fiscal 2012, bakery products sales amounted to 32% of the Company�� sales.
Frozen Beverages
The Company markets frozen beverages primarily under the names ICEE, SLUSH PUPPIE, PARROT ICE and ARCTIC BLAST in the United States, Mexico and Canada. During fiscal 2012, frozen beverages are sold in the Frozen Beverages segment. During fiscal 2012, frozen beverage sales amounted to 16% of revenue in fiscal 2012.
Under the Company�� principal marketing program for frozen carbonated beverages, it installs frozen beverage dispensers for its ICEE and ARCTIC BLAST brands at customer locations and thereafter services the machines, arranges to supply customers with ingredients required for production of the frozen beverages, and supports customer retail sales efforts with in-store promotions and point-of-sale materials. During fiscal 2012, the Company also provided repair and maintenance service to customers for customers��owned equipment and sells equipment in its Frozen Beverages segment, revenue from which amounted to 7% of sales. The Company sells frozen un-carbonated beverages under the SLUSH PUPPIE and PARROT ICE brands through a distributor network and through its own distribution network.
Each new frozen carbonated customer location requires a frozen beverage dispenser supplied by the Company or by the customer. Company-supplied frozen carbonated dispensers are purchased from outside vendors, built new or rebuilt by the Company. The Company provides managed service and/or products to approximately 87,000 Company-owned and customer-owned dispensers.
Other Products
Other products sold by the Company include soft drinks, funnel cakes sold under the FUNNEL CAKE FACTORY brand name and smaller amounts of various other food products. These products are sold in the Food Service and Frozen Beverages segments.
Advisors' Opinion:- [By John Kell and Lauren Pollock var popups = dojo.query(".socialByline .popC"); ]
Hologic Inc.(HOLX) named Eric Compton as its chief operating officer, a newly created position, amid a handful of leadership changes at the medical-equipment maker. Mr. Compton most recently worked as the world-wide president of Johnson & Johnson’s Ortho-Clinical Diagnostics. J&J(JJSF) in January agreed to sell the�blood-testing business for $4.15 billion to Carlyle Group L.P(CG).
- [By Geoff Gannon] out the performance numbers on those three stocks over the last 10-13 years (I bought them at different times). You��l notice that if I just never sold those stocks I wouldn�� need to do anything else. Those three stocks would��e made a fine portfolio for the next decade or so.
Well, I did sell those stocks. And I did a lot else. And some of it worked very well and some of it worked very badly. But, almost without fail, the net result was never better than what would have happened if I�� kept those three stocks.
That�� not an accident. It took me a very, very long time to buy stocks when I was a kid. I bought six stocks in my first five years as an investor. That�� not quite a 20 punches approach ��but it�� pretty close.
Why did I only buy one stock a year?
Because I didn�� know anything about stocks. And I didn�� think I knew anything about stocks.
My investment style was formed from a combination of extreme ignorance and extreme confidence. I was totally ignorant about stocks. And I was totally confident that I could learn all I needed to know about the stocks I needed to know about.
That combination led to focusing on a few very specific stocks. Stocks I was comfortable with.
When I was 14, there were only two places my money went. Into my brokerage account. Or into video games. So it�� not a surprise I bought Activision. At the time the video game industry had a much clearer future than it does today. And there was no better CEO of a video game company than Bobby Kotick. The balance sheet was pristine. When you backed out cash, the stock was cheap relative to sales. I looked at everything I could about video game companies and I decided sales were pretty profitable and pretty cash generative in this industry. All you needed was sensible capital allocation. All you needed was management that was going to run the place like a business. And I thought you had that.
I worked as a cashier at Vi
Best Japanese Companies For 2014: Unifi Inc (UFI)
Unifi, Inc., sells fibers made from polyester and nylon filament to other yarn manufacturers, knitters and weavers that produce fabric for the apparel, hosiery, sock, home furnishing, automotive upholstery, industrial and other markets. The Company's polyester yarn products include polyester polymer beads (Chip), partially oriented yarn (POY), textured, solution and package dyed, twisted and beamed yarns. The Company's nylon products include textured, solution dyed and covered spandex products. The Company operates in three segments: Polyester segment, Nylon segment and International segment. In December 2013, Unifi Inc acquired American Drawtech Co Inc.
The Polyester segment manufactures Chip, POY, textured, dyed, twisted and beamed yarns, virgin and recycled, with sales primarily to other yarn manufacturers, knitters and weavers that produce yarn and/or fabric for the apparel, hosiery, automotive upholstery, home furnishing, industrial and other end-use markets. The Polyester segment consists of manufacturing operations in the United States and El Salvador. The Nylon segment manufactures textured nylon and covered spandex yarns with sales to knitters and weavers that produce fabric for the apparel, hosiery, sock and other end-use markets. The Nylon segment consists of manufacturing operations in the United States and Colombia. The International segment's products primarily include textured polyester and range of resale yarns. The International segment sells its yarns to knitters and weavers that produce fabric for the apparel, automotive upholstery, home furnishing, industrial and other end-use markets primarily in the South American and Asian regions.
The Company manufactures polyester related products in the United States, El Salvador and Brazil and nylon yarns in the United States and Colombia for a range of end-uses. The Company processes and sells POY, as well as high-volume commodity, specialty, and PVA yarns, domestically and internationally, with PVA yarns making up! approximately 18% consolidated sales for the fiscal year ended June 24, 2012.
The Company competes with O'Mara, Inc., NanYa Plastics Corp., AKRA, S.A. de C.V., C S Central America S.A. de C.V., Avanti Industria Comercio Importacao e Exportacao Ltda., Polyenka Ltda., Sapona Manufacturing Company, Inc., McMichael Mills, Inc. and Worldtex, Inc.
Advisors' Opinion:- [By Javier Hasse, Insider Monkey]
Once again, MedAssets trades below its industry average valuation of 62.1 x P/E, at 49.3x. Its valuation becomes even more attractive when one looks at the company麓s P/B ratio (2.8x vs. an industry average of 15.6x) and P/S ratio (2.0x vs. 4.7x). However, below average margins, returns and growth projections are three major sources of concern.
Unifi (UFI)Finally, there’s Unifi (UFI), a $421 million market cap diversified producer and processor of multi-filament polyester and nylon yarns.
Best Japanese Companies For 2014: Argos Therapeutics Inc (ARGS)
Argos Therapeutics, Inc (Argos), incorporated on May 8, 1997, is a development stage biopharmaceutical company. The Company is focused on the development and commercialization of personalized immunotherapies for the treatment of cancer and infectious diseases based on its technology platform called Arcelis. The Company�� advanced product candidate is AGS-003 for the treatment of metastatic renal cell carcinoma, (mRCC). As of December 31, 2010, the Company was developing a second Arcelis-based product candidate, AGS-004 for the treatment of human immunodeficiency virus (HIV), and two other product candidates: AGS-009, a monoclonal antibody for the treatment of lupus, and AGS-010, a preclinical biologic compound for the treatment of psoriasis and for organ transplantation.
The Company uses its Arcelis platform to generate Ribonucleic Acid (RNA) loaded dendritic cell immunotherapies using biological components derived from the individual patient to be treated. It manufactures these personalized therapies using that patient�� disease sample, either tumor cells in the case of cancer or a blood sample containing virus in the case of infectious disease, and dendritic cells derived from the patient�� white blood cells. The Company�� AGS-003 is tested in clinical trials in combination with sunitinib and as a monotherapy for the treatment of mRCC.
Advisors' Opinion:- [By gurujx]
Argos Therapeutics Inc (ARGS) Reached the 3-year Low of $6.52
The prices of Argos Therapeutics Inc (ARGS) shares have declined to close to the 3-year low of $6.52, which is 54.8% off the 3-year high of $13.74.
- [By John Udovich]
Last week had been a busy week for biotech IPOs and follow-on offerings plus news from small cap biotech stocks like Omeros Corporation (NASDAQ: OMER), Argos Therapeutics Inc (NASDAQ: ARGS), Revance Therapeutics Inc (NASDAQ: RVNC) and TNI BioTech (OTCMKTS: TNIB) that�� worth noting as a new trading week begins:�
Best Japanese Companies For 2014: Basf SE (BASFY.PK)
BASF SE is a chemical company. The Company operates in six segments: Chemicals, Plastics, Performance Products, Functional Solutions, Agricultural Solutions and Oil & Gas. Chemicals segment offers products in the chemical, electronic, construction, textile, automotive, pharmaceutical and agricultural industries. Plastics segment offers a range of products, system solutions and services. Performance Products help its customers to improve their products and processes. Functional Solutions segment bundles system solutions and products for customers and industries. The Company�� Agricultural Solutions segment includes crop protection products, which guard against fungal diseases, insects and weeds. Its Oil & gas segment is a producer of oil and gas. On April 9, 2009, the Company acquired Ciba Holding AG. In April 2010, Intertek Group plc acquired the Regulatory and Safety Testing businesses of Ciba Expert Services (Ciba ES) from the Company. In December 2010, the Company completed its acquisition of Cognis Holding GmbH from Cognis Holding Luxembourg S.a r.l.
Chemicals
The Company�� Chemicals segment portfolio ranges from basic chemicals, glues and electronic chemicals for the semiconductor and flat panel display industry, to solvents and plasticizers, as well as starting materials for detergents, plastics, textile fibers, paints, coatings and pharmaceuticals. This segment is organized into three divisions: Inorganics, Petrochemicals and Intermediates. The important basic products of the Inorganics division are ammonia, methanol, sodium hydroxide, chlorine, as well as sulfuric and nitric acid. The Petrochemicals division produces products, such as ethylene, propylene, butadiene and benzene, which are produced in steam crackers from naphtha or natural gas. In further processing stages, it produces alcohols, solvents and plasticizers for the chemicals and plastics industries. BASF SE�� Intermediates division develops, produces and markets a range of intermediates of all produc! ers worldwide. The product lines include amines, diols, polyalcohols, acids and specialties. They serve as starting materials for products, such as coatings, plastics, pharmaceuticals, textile fibers, crop protection products, as well as detergents and cleaners.
Plastics
BASF�� Plastics segment is organized into two divisions: Performance Polymers and Polyurethanes. The Performance Polymers division is a supplier of engineering plastics, polyamides and polyamide intermediates, foams and specialty plastics. The Company offers its customers a portfolio of engineering plastics based on polyamide 6 and polyamide 6,6. This is complemented by products Ultradur, Ultraform and Ultrason. For the packaging, textile and food industries, it offers Ultramid, a base product for the manufacturing of fibers and foils. BASF SE�� product range also includes Ecoflex and Ecovio, biodegradable specialty plastics for the packaging industry. Styropor and its refinement Neopor are styrene-based precursors for foams used in insulating material for construction and packaging. The Polyurethanes division is a supplier of basic products, systems and specialties. The Company offers polyurethane products for numerous customer applications. Under brand names, such as Elastoflex and Elastopor, polyurethanes are used, as rigid or flexible foams in construction for furniture and household appliances.
Performance Products
The Performance Products segment consists of the Acrylics & Dispersions, Care Chemicals and Performance Chemicals divisions. Acrylics & Dispersions produces acrylic acid, as well as its derivatives superabsorbents and polymer dispersions. Superabsorbents are used particularly in diapers. Polymer dispersions are used in the production of glues, coatings, nonwoven materials and construction chemicals. The Company�� product portfolio for the paper industry consists of binders, process chemicals and kaolin pigments. Its Care Chemicals portfolio consists of products f! or cleani! ng, care, cosmetics and hygiene. Performance Chemicals pools specialties for various customer industries. The product portfolio consists of antioxidants, pigments, light stabilizers and specialty additives. The division also makes chemicals for the production and finishing of leather and textiles.
Functional Solutions
The Functional Solutions segment consists of the Catalysts, Construction Chemicals and Coatings divisions. The Catalysts division develops catalysts and adsorbents. It produces catalysts that transform pollutants in the exhaust flows of vehicles into harmless chemical and plastics. The Construction Chemicals division is engaged in development of concrete admixtures, such as concrete plasticizers, deferrers and curing agents. It also produces and markets construction systems. The Coatings division is a provider of coatings solutions for automotive and industrial applications. Its brands Glasurit and R-M are for the car refinish business.
Agricultural Solutions
The Agricultural Solutions segment consists of the Crop Protection division. The Company develops and produces active ingredients and formulations for the improvement of crop health and yields, and markets them worldwide. Its portfolio includes fungicides, insecticides, herbicides and seed treatments. Its product Headline contains the active ingredient F500, which is not only used for corn and soybean, but also for numerous other crops.
Oil & Gas
BASF�� oil and gas activities are bundled in the Wintershall Group. Wintershall and its subsidiaries operate in the business sectors exploration and production, and natural gas trading. In the exploration and production of oil and natural gas, the Company focuses on oil and gas regions in Europe, North Africa and South America, as well as Russia and the Caspian Sea region. The Mittelplate oil field in the North Sea tidal flats is the cornerstone of the Company�� oil production in Germany. Wintershall and RWE-D! EA each h! old a 50% interest in this field. During the year ended December 31, 2009, it acquired 25% interest in Cuxhaven concession. It operates 26 offshore platforms in Mittelplate region, of which 19 are actually controlled. In Libya, Wintershall operates eight onshore oil fields in the concessions 96 and 97 and exploits the associated gas released during crude oil production in a gas utilization plant for the local demand. In Mauritania, it operates two onshore exploration blocks. In 2008, Wintershall acquired stakes of 50% each in two exploration areas in the Canadon Asfalto Basin. It supplies Germany and several other European countries. The gas pipeline network operated by WINGAS TRANSPORT connects the markets in Western Europe with a natural gas infrastructure that runs through Eastern Europe and the Russian Federation all the way to the gas fields in Siberia. Other components portfolio include natural gas storage facility in Western Europe, in Rehdn, Germany, and the natural gas storage facility in Haidach, Austria.
Advisors' Opinion:- [By Markus Aarnio]
BioAmber expects its advanced bio-based specialty chemicals to compete with petrochemical equivalents that are proven in the market and manufactured by established companies, such as Gadiv Petrochemical Industries, Kawasaki Kasei, DSM (RDSMY.PK) and numerous small Chinese producers including Anqing Hexing Chemical, and Anhui Sunsing Chemicals. In addition, BioAmber's products will compete against other companies in the bio-based specialty chemical industry, both early stage companies, such as Genomatica (for bio-based 1,4 BDO) and Myriant Corporation (for bio-succinic acid), and established companies, such as a collaborative venture between DSM and Roquette Frères S.A. and a collaborative venture between BASF (BASFY.PK) and Purac (both for bio-succinic acid).
J. Scott Applewhite/APSenate Majority Leader Harry Reid. WASHINGTON -- With a week left to hammer out a deal to avoid a government shutdown, some lawmakers seem resigned -- if not rushing -- to that end. Most say they don't want the first government shutdown since 1996. But if the government happens to shut down, so be it. Republicans say it is part of their effort to dismantle Democrats' health care overhaul, while Democrats defending the law recall that similar standoffs gave them political gains. And fingers were already being pointed just to be on the safe side. "I believe we should stand our ground," said Sen. Ted Cruz, a tea party darling from Texas who pushed fellow Republicans to link a temporary budget bill with a provision to defund the Affordable Care Act. Some Republicans have vowed to shut down the government unless they can stop the law from taking hold. Cruz and fellow tea party conservatives on Sunday said President Barack Obama and his Democratic allies would be to blame if they don't accede to demands to strike the national health care law. "If Harry Reid kills that [demand], Harry Reid is responsible for shutting down the government," Cruz said Sunday. The tactic won sharp criticism from Democrats and even some Republicans, well aware the shutdown in the-mid 1990s helped President Bill Clinton regain his political footing and win a second term. House Democratic Leader Nancy Pelosi called supporters of the defund-or-else strategy "legislative arsonists." Sen. Tom Coburn, R-Okla., said the effort would not accomplish its goal and was unrealistic. And the president had a direct message to those backing efforts to roll back his health law: "Let me say as clearly as I can: It is not going to happen." The Republican-led House on Friday approved legislation designed to wipe out the 3-year-old health care law. Yet Senate Democratic Leader Harry Reid vowed to keep the health law intact despite Republicans' attempts. And there's virtually no chance Obama would sign such a measure if it were to ever reach his desk. That doesn't mean conservatives -- especially the younger lawmakers closely aligned with the tea party -- are going to stop with their demands. Rep. Tom Graves, R-Ga., said the goal was to defund the president's health care legislation for at least one more year, if not forever. If the government shuts down, it will be because Obama refused to compromise, he said. "We do have eight days to reach a resolution on this, and I propose an idea that kept the government operating and opened for an entire year while delaying and defunding Obamacare for a year so that we could work out those differences," Graves said, appearing on his first national Sunday program. Left unsaid: It would require Obama to abandon his chief domestic accomplishment. "We don't want to shut down the government," said Rep. Matt Salmon, R-Ariz. "I want to make it clear: We want to shut down Obamacare." The unyielding political posturing comes one week before Congress reaches an Oct. 1 deadline to dodge any interruptions in government services. While work continues on a temporary spending bill, a potentially more devastating separate deadline looms a few weeks later when the government could run out of money to pay its bills. Lawmakers are considering separate legislation that would let the United States avoid a first-ever default on its debt obligations. House Republicans are planning legislation that would attach a 1-year delay in the health care law in exchange for ability to increase the nation's credit limit of $16.7 trillion. "I cannot believe that they are going to throw a tantrum and throw the American people and our economic recovery under the bus," said Sen. Claire McCaskill, a Missouri Democrat Even within his own party, Cruz faced skepticism. "It's not a tactic that we can actually carry out and be successful," Coburn said. Cruz and McCaskill were interviewed on "Fox News Sunday." Pelosi spoke to CNN's "State of the Union." Coburn and Salmon were on CBS' "Face the Nation." Graves was on ABC's "This Week."